只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-24 2026-07-28 | RTX RTX Corp | DaSilva Kevin G Officer · Senior VP and Treasurer | 卖出（S） | 4,760 | US$213.62 | US$101.68万 | 22,349.1004 | SEC |
| 2026-07-24 2026-07-28 | RTX RTX Corp | Brunk Troy D Officer · President, Collins Aerospace | 卖出（S） | 1,811 | US$210.65 | US$381,478.10 | 21,409.1118 | SEC |
| 2026-07-24 2026-07-28 | RTX RTX Corp | Brunk Troy D Officer · President, Collins Aerospace | 卖出（S） | 6,746 | US$210.20 | US$141.8万 | 8,809.1118 | SEC |
| 2026-07-02 2026-07-07 | VRTX VERTEX PHARMACEUTICALS INC / MA | McKechnie Duncan Officer · EVP, Chief Commercial Officer | 卖出（S） | 1,541 | US$519.00 | US$799,779.00 | 11,001 | SEC |
| 2026-07-02 2026-07-07 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania Officer · EVP, Chief Reg. & Quality Off. | 卖出（S） | 1,500 | US$524.99 | US$787,485.00 | 45,321 | SEC |
| 2026-07-01 2026-07-06 | VRTX VERTEX PHARMACEUTICALS INC / MA | Liu Joy Officer · EVP and Chief Legal Officer | 卖出（S） | 828 | US$502.71 | US$416,243.88 | 19,131 | SEC |
| 2026-06-26 2026-06-30 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen Officer · EVP and CMO | 卖出（S） | 596 | US$482.50 | US$287,570.00 | 15,337 | SEC |
| 2026-06-18 2026-06-23 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen Officer · EVP and CMO | 卖出（S） | 1,020 | US$462.17 | US$471,413.40 | 15,933 | SEC |
| 2026-06-15 2026-06-17 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen Officer · EVP and CMO | 卖出（S） | 4,062 | US$450.00 | US$182.79万 | 16,953 | SEC |
| 2026-06-05 2026-06-09 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen Officer · EVP and CMO | 卖出（S） | 1,745 | US$450.00 | US$785,250.00 | 21,015 | SEC |
| 2026-06-01 2026-06-03 | VRTX VERTEX PHARMACEUTICALS INC / MA | Liu Joy Officer · EVP and Chief Legal Officer | 卖出（S） | 828 | US$439.91 | US$364,245.48 | 19,959 | SEC |
| 2026-05-29 2026-06-02 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen Officer · EVP and CMO | 卖出（S） | 1,974 | US$450.00 | US$888,300.00 | 22,760 | SEC |
| 2026-05-15 2026-05-19 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen Officer · EVP and CMO | 卖出（S） | 1,354 | US$453.45 | US$613,971.30 | 24,734 | SEC |
| 2026-05-15 2026-05-19 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bunnage Mark E. Officer · EVP, Chief Scientific Officer | 卖出（S） | 33 | US$453.45 | US$14,963.85 | 7,284 | SEC |
| 2026-05-12 2026-05-14 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen Officer · EVP and CMO | 卖出（S） | 6,988 | US$450.00 | US$314.46万 | 26,088 | SEC |
| 2026-05-04 2026-05-05 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bhatia Sangeeta N. Director | 卖出（S） | 318 | US$423.73 | US$134,746.14 | 4,924 | SEC |
| 2026-05-01 2026-05-05 | VRTX VERTEX PHARMACEUTICALS INC / MA | Liu Joy Officer · EVP and Chief Legal Officer | 卖出（S） | 1,104 | US$425.02 | US$469,222.08 | 20,729 | SEC |
| 2026-04-01 2026-04-03 | VRTX VERTEX PHARMACEUTICALS INC / MA | Liu Joy Officer · EVP and Chief Legal Officer | 卖出（S） | 978 | US$449.17 | US$439,288.26 | 21,833 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| TRTXPC | 749 | 0 | 874.6183 | 85.64% | Q |
| TRTX | 188,318.4696 | 682 | 333,661.1346 | 56.44% | B, Q, N |
| HRTX | 470,632 | 7,100 | 948,431.7176 | 49.62% | B, Q, N |
| XRTX | 1,535 | 0 | 3,344.0222 | 45.90% | B, Q |
| VRTX | 118,382.286 | 192 | 281,668.0039 | 42.03% | B, Q, N |
| RTX | 354,601.0728 | 1,235 | 1,195,598.7912 | 29.66% | B, Q, N |
| RTXG | 2,435 | 0 | 8,841.5837 | 27.54% | Q, N |
| BRTX | 111,790 | 2,047 | 596,060.3747 | 18.75% | B, Q, N |